Stock Price
1,191.15
Daily Change
8.65 0.73%
Monthly
-3.57%
Yearly
-0.05%
Q1 Forecast
1,189.51

Aurobindo Pharma reported INR88.91B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Cipla INR 7.96B 39.9M Sep/2025
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Hindustan Unilever INR 44.42B 16.29B Sep/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
UPL INR 41.52B 53.85B Sep/2025